1. Home
  2. LIVE vs FGEN Comparison

LIVE vs FGEN Comparison

Compare LIVE & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Live Ventures Incorporated

LIVE

Live Ventures Incorporated

HOLD

Current Price

$14.00

Market Cap

30.3M

ML Signal

HOLD

Logo FibroGen Inc

FGEN

FibroGen Inc

HOLD

Current Price

$9.70

Market Cap

35.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIVE
FGEN
Founded
1968
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.3M
35.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
LIVE
FGEN
Price
$14.00
$9.70
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$146.50
AVG Volume (30 Days)
12.2K
26.2K
Earning Date
12-11-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
4.93
53.38
Revenue
$444,944,000.00
$8,298,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.84
$0.16
Revenue Growth
N/A
N/A
52 Week Low
$6.25
$4.85
52 Week High
$25.88
$21.94

Technical Indicators

Market Signals
Indicator
LIVE
FGEN
Relative Strength Index (RSI) 64.17 57.91
Support Level $9.05 $8.37
Resistance Level $17.35 $9.09
Average True Range (ATR) 1.55 0.45
MACD 0.77 0.17
Stochastic Oscillator 70.33 84.46

Price Performance

Historical Comparison
LIVE
FGEN

About LIVE Live Ventures Incorporated

Live Ventures Inc is a holding company for diversified businesses. It is focused on acquiring and operating profitable companies in various industries. The company operates in the business segments of Retail Entertainment which includes direct sales of entertainment and appliance products and services, Flooring Manufacturing, Steel Manufacturing, which includes the sale of steel plates, ground flat stock, and drill rods, and Corporate and Other. It derives key revenue from the Flooring Manufacturing segment which includes the manufacturing of carpets and rugs, yarn products, as well as a reseller of hard surface flooring products. Geographically the activities are carried out throughout the United States.

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

Share on Social Networks: